Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?

Neurology

Volumn 71, Issue 19, 2008, Pages 1550-1552

  Lesage, S ^a,b,c   Belarbi, S ^d   Troiano, A ^a,b,c   Condroyer, C ^a,b,c   Hecham, N ^d   Pollak, P ^e   Lohman, E ^a,b,c   Benhassine, T ^f,g   Ysmail Dahlouk, F ^d   Durr A ^a,b,c   Tazir, M ^d   Brice, A ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d CHU Mustapha   (Algeria)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^g Institut Pasteur d'Algerie   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LEVODOPA; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROL GROUP; CONTROLLED STUDY; DYSKINESIA; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NORTH AFRICA; PARKINSON DISEASE; PRIORITY JOURNAL; ADOLESCENT; AFRICA; CHILD; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; POINT MUTATION;

ADOLESCENT; ADULT; AFRICA, NORTHERN; AGED; AGED, 80 AND OVER; CHILD; DYSKINESIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 56149125336     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000338460.89796.06     Document Type: Article

References (7)

1. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
2. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
3. Brice A. Genetics of Parkinson's disease: LRRK2 on the rise. Brain 2005;128:2760-2762.
4. Lesage S, Durr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 2006;354:422-423.
5. Ishihara L, Gibson RA, Warren L, et al. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord 2007;22:55-61.
6. Wang J, Liu ZL, Chen B. Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD. Neurology 2001;56:1757-1759.
7. Kaiser R, Hofer A, Grapengiesser A, et al. L-dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Neurology 2003;60:1750-1755.